Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG
Memorial Cancer Institute showcases the Best of ASCO® 2025 franchise by the American Society of Clinical Oncology at its annual meeting, which attracts 55,000 attendees and features 5,000 presentations.
The institute, holding the exclusive franchise for South Florida for a decade, emphasises education and cancer care. With over 60 speakers and 350 registered participants, the event highlights the strong local interest in healthcare education.
Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG
ASCO 2025: Developments in the treatment of soft tissue sarcoma
Updates on gastrointestinal cancer treatments ASCO 2025
Latest advances in chronic lymphocytic leukaemia
Understanding Zimbabwe's pharmacovigilance system
Interpreting the results of a clinical trial
Breast cancer screening global approaches
Breast cancer staging and biological subtypes clinical application
Bethesda and Beyond – Improving results of FNAC in thyroid nodules